PATH-06. SURVIVAL ANALYSIS FOR ADULT MIDLINE GLIOMA: DO ADULT MIDLINE GLIOMAS WITH THE H3 K27M MUTATION REALLY HAVE POOR PROGNOSIS?
نویسندگان
چکیده
Abstract PURPOSE Since it is known that midline located glioma with H3K27 mutation in children has a disastrous prognosis, 2016 WHO classification, these tumors were defined as diffuse (DMG) and classified grade IV. A lot of papers about pediatric DMG have been published, but there are not many adult DMG. In this study, we aimed to identify factors affecting the prognosis glioma. This first paper study according histological largest investigate survival METHODS We reviewed chart patients diagnosed H3K27M after undergoing resection or biopsy among who visited our institution between January 2010 December 2020. Survival analysis was performed tumor location, grading, Karnofsky Performance Scale (KPS), age. RESULTS Among 125 gliomas identified, 45 (36.0%) had mutation. As result on gliomas, low grade, KPS ≥ 80, age ≤ 60 showed significantly better survival. After adjusting for age, difference wildtype group significant. DMG, total resection, concurrent chemoradiation therapy CONCLUSION glioma, due observed children. The determined by KPS, extent resection. Therefore, current which classifies all mutant IV regardless diagnoses, suitable adults.
منابع مشابه
Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
BACKGROUND AND PURPOSE The 2016 World Health Organization Classification of Tumors of the Central Nervous System includes "diffuse midline glioma with histone H3 K27M mutation" as a new diagnostic entity. We describe the MR imaging characteristics of this new tumor entity in pediatric patients. MATERIALS AND METHODS We retrospectively reviewed imaging features of pediatric patients with midli...
متن کاملAbsence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Letter According to the revised 4th edition of the WHO classification of tumors of the CNS, diffuse midline gliomas, H3 K27M-mutant (DMG) are molecularly defined as tumors with a predominantly astrocytic differentiation carrying mutations in the histone H3 encoding genes H3F3A (histone H3.3), HIST1H3B (H3.1) or HIST1H3C (H3.2) [9]. The vast majority of DMG demonstrate typical features of gliobl...
متن کاملDiffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma
Recent studies have identified that K27M mutation in either the H3F3A or HIST1H3B genes, which encode the histone H3 variants H3.3 and H3.1, define the majority of diffuse gliomas arising in midline structures including the thalamus, brainstem, and spinal cord in both children and adults [8, 10]. These “diffuse midline gliomas, H3 K27M-mutant” are associated with poor prognosis regardless of hi...
متن کاملCo-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
Ganglioglioma (GG) is a grade I tumor characterized by alterations in the MAPK pathway, including BRAF V600E mutation. Recently, diffuse midline glioma with an H3 K27M mutation was added to the WHO 2016 classification as a new grade IV entity. As co-occurrence of H3 K27M and BRAF V600E mutations has been reported in midline tumors and anaplastic GG, we searched for BRAF V600E and H3 K27M mutati...
متن کاملH3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis
BACKGROUND H3 K27M mutation was originally described in pediatric diffuse intrinsic pontine gliomas (DIPGs), but has been recently recognized to occur also in adult midline diffuse gliomas, as well as midline tumors with other morphologies, including gangliogliomas (GGs), anaplastic GGs, pilocytic astrocytomas (PAs), and posterior fossa ependymomas. In a few patients with H3 K27M;mutant tumors ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2022
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noac209.579